Unfortunately, you have no business picking stocks. That is a scam, and I am going to break down why.
From the FIRST PAGE of the annual report (did you even read this?):
Without qualifying our opinion, we draw attention to Note 1 in the financial statements which indicates that the Company incurred a net loss of $1,102,491 during the year ended September 30, 2013, has an accumulated deficit of $4,656,546 and has a working capital deficiency at September 30, 2013 of $999,440. These conditions, along with other matters as set forth in Note 1, indicate the existence of material uncertainties that may cast significant doubt about the Company’s ability to continue as a going concern.
This is the opinion of the AUDITOR.
Moving along.
CURRENT ASSETS
Cash and cash equivalents $ 5,327
Yup, this company has $5,327 Canadian dollars. Not $5,327 thousand. $5,327. That's it. That's their whole bank account.
Abattis Bioceuticals Corp. (the "Company" or "Abattis") was incorporated as Sinocan Capital Group Inc. under the Company Act (Canada British Columbia) on June 30, 1997 and listed and began trading on the Canadian National Stock Exchange (“the Exchange”) under the symbol “FLU” on December 23, 2010. The Company’s head office is located at Suite 1000 – 355 Burrard Street, Vancouver, British Columbia, V6C 2G8, Canada.
Oh, well isn't that interesting! "FLU". Hm, that doesn't sound much like a ticker symbol for a pot stock.
Looking at the annual report from 2009...
The company was incorporated as Sinocan Capital Group Inc. under the Company Act (British Columbia) on June 30, 1997 and was classified as a Capital Pool Company ("CPC") as defined in the TSX Venture Exchange ("TSX") Policy 2.4. On September 29, 1997, the Company changed its name to Sican Ventures, Inc. The Company was listed on the Canadian Venture Exchange on May 20, 1999. On April 16, 2009, the Company entered into an agreement with PRB Pharmaceuticals, Inc. ("PRB") and Pacific Bio-Pharmaceuticals, Inc. ("Pacific Bio") for the purchase of their interest in patents and intellectual property related to anti-viral products designed to prevent avian influenza in humans and poultry (Note 6).
Let's get in our time machine and go allllll the way back to 2001's annual report...
SICAN VENTURES INC
The Company entered into an agreement, dated October 10, 2000, with Stanfeld International Ltd. to purchase a 40% interest in an oil and gas reservoir located in central Alberta. The completion of this agreement will constitute the Company's qualifying transaction pursuant to the policies of the Canadian Venture Exchange. The agreement will be subject to regulatory approval.
I'm gonna stop now.
Buy index funds, OK?